US$ 24.08
tirzepatide harrisburg nc Flex-Dose 3 mL Injectable 10 mg/mL Tirzepatide, Glycine + Vitamin B12
Description
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT2): a doubleblind, randomised, multicentre, placebocontrolled, phase 3 trial

Targeting both GIP and GLP1 is believed to enhance weight loss compared with medications that focus solely on GLP1
Degraded peptide delivers reduced potency regardless of how accurately you calculated the dose

But it has a different job

Int J Mol Sci 16(9):2019520211
